{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T08:49:21Z","timestamp":1775638161609,"version":"3.50.1"},"reference-count":58,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T00:00:00Z","timestamp":1688601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fundo Europeu de Desenvolvimento Regional (FEDER)","award":["IF\/00092\/2014\/CP1255\/CT0004"],"award-info":[{"award-number":["IF\/00092\/2014\/CP1255\/CT0004"]}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia (FCT)","award":["IF\/00092\/2014\/CP1255\/CT0004"],"award-info":[{"award-number":["IF\/00092\/2014\/CP1255\/CT0004"]}]},{"name":"Faculty of Medicine, University of Porto (FMUP)","award":["IF\/00092\/2014\/CP1255\/CT0004"],"award-info":[{"award-number":["IF\/00092\/2014\/CP1255\/CT0004"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Dopamine is a neurotransmitter that plays an important role within the brain by regulating a wide variety of cognitive and emotional processes. In cancer, its role is distinct and uncertain, but it is characterized by the interaction with its receptors that may be in the tumor cells; we have examples of different types of cancer with this characteristic, of which breast and colon cancer stand out. It is believed that dopamine and some of its receptors also influence other cellular processes such as cell proliferation, survival, migration, and invasion. The potential of these receptors has allowed the exploration of existing drugs, originally developed for non-oncological purposes, for the possible treatment of cancer. However, regarding the repurposing of drugs for cancer treatment, the role of dopamine is not so straightforward and needs to be clarified. For this reason, this review intends to present concepts associated with twelve drugs reused for oncology based on dopamine and its receptors. Some of them can behave as antagonists and inhibit tumor cell growth leading to cell death. Attention to this group of drugs may enhance the study of other pharmacological conditions such as signaling pathways related to cell proliferation and migration. Modulation of these pathways using drugs originally developed for other conditions may offer potential therapeutic opportunities in oncology. It is important to note that while the repurposing of oncology drugs based on dopamine signaling is promising, further studies are still needed to fully understand the mechanisms involved and determine the clinical efficacy and safety of these approaches.<\/jats:p>","DOI":"10.3390\/biomedicines11071917","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T02:28:46Z","timestamp":1688696926000},"page":"1917","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The Role of Dopamine in Repurposing Drugs for Oncology"],"prefix":"10.3390","volume":"11","author":[{"given":"Catarina","family":"Moura","sequence":"first","affiliation":[{"name":"OncoPharma Research Group, Center for Health Technology and Services Research (CINTESIS), Rua Doutor Pl\u00e1cido da Costa, 4200-450 Porto, Portugal"},{"name":"CINTESIS@RISE, Faculty of Medicine, University of Porto, Alameda Professor Hern\u00e2ni Monteiro, 4200-319 Porto, Portugal"},{"name":"ICBAS\u2014School of Medicine and Biomedical Sciences, University of Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1283-1042","authenticated-orcid":false,"given":"Nuno","family":"Vale","sequence":"additional","affiliation":[{"name":"OncoPharma Research Group, Center for Health Technology and Services Research (CINTESIS), Rua Doutor Pl\u00e1cido da Costa, 4200-450 Porto, Portugal"},{"name":"CINTESIS@RISE, Faculty of Medicine, University of Porto, Alameda Professor Hern\u00e2ni Monteiro, 4200-319 Porto, Portugal"},{"name":"Department of Community Medicine, Information and Health Decision Sciences (MEDCIDS), Faculty of Medicine, University of Porto, Rua Doutor Pl\u00e1cido da Costa, 4200-450 Porto, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"127202","DOI":"10.1016\/j.colsurfa.2021.127202","article-title":"Studies on cancer cell death through delivery of dopamine as anti-cancer drug by a newly functionalized cobalt ferrite nano-carrier","volume":"627","author":"De","year":"2021","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"104970","DOI":"10.1016\/j.bandl.2021.104970","article-title":"Dopamine, vocalization, and astrocytes","volume":"219","author":"Turk","year":"2021","journal-title":"Brain Lang."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.4103\/1673-5374.284976","article-title":"Dopamine: An immune transmitter","volume":"15","author":"Broome","year":"2020","journal-title":"Neural Regen. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10571-018-0632-3","article-title":"Dopamine: Functions, Signaling, and Association with Neurological Diseases","volume":"39","author":"Klein","year":"2019","journal-title":"Cell Mol. Neurobiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.7150\/jca.27780","article-title":"The Prospective Value of Dopamine Receptors on Bio-Behavior of Tumor","volume":"10","author":"Wang","year":"2019","journal-title":"J. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/14737140.2022.1987221","article-title":"Repurposing antipsychotic drugs for cancer treatment: Current evidence and future perspectives","volume":"22","author":"Lianos","year":"2022","journal-title":"Expert Rev. Anticancer Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1124\/jpet.119.256818","article-title":"Cancer and the Dopamine D(2) Receptor: A Pharmacological Perspective","volume":"370","author":"Weissenrieder","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"15330338211027913","DOI":"10.1177\/15330338211027913","article-title":"Dopamine receptors in cancer: Are they valid therapeutic targets?","volume":"20","year":"2021","journal-title":"Technol. Cancer Res. Treat."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/carcin\/bgac045","article-title":"Understanding the role of dopamine in cancer: Past, present and future","volume":"43","author":"Grant","year":"2022","journal-title":"Carcinogenesis"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Speranza, L., Di Porzio, U., Viggiano, D., de Donato, A., and Volpicelli, F. (2021). Dopamine: The neuromodulator of long-term synaptic plasticity, reward and movement control. Cells, 10.","DOI":"10.3390\/cells10040735"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1210\/en.2010-0745","article-title":"Minireview: New roles for peripheral dopamine on metabolic control and tumor growth: Let\u2019s seek the balance","volume":"151","author":"Maechler","year":"2010","journal-title":"Endocrinology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41423-020-0477-9","article-title":"Regulation of natural killer cell activity by glucocorticoids, serotonin, dopamine, and epinephrine","volume":"17","author":"Capellino","year":"2020","journal-title":"Cell Mol. Immunol."},{"key":"ref_13","unstructured":"Purves, D., Augustin, G.J., Fitzpatrick, D., Hall, W.C., LaMantia, A.-S., Mooney, R.D., Platt, M.L., and White, L.E. (2018). Neuroscience, Oxford University Press. [6th ed.]."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/1523-1747.ep12543559","article-title":"Enhancement of L-dopa incorporation into melanoma by dopa decarboxylase inhibition","volume":"70","author":"Wick","year":"1978","journal-title":"J. Investig. Dermatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.18632\/oncotarget.28010","article-title":"Multifaceted effect of chlorpromazine in cancer: Implications for cancer treatment","volume":"12","author":"Brelidze","year":"2021","journal-title":"Oncotarget"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.cbi.2019.01.033","article-title":"The antipsychotic chlorpromazine suppresses YAP signaling, stemness properties, and drug resistance in breast cancer cells","volume":"302","author":"Yang","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"27580","DOI":"10.18632\/oncotarget.4768","article-title":"Repositioning antipsychotic chlorpromazine for treating colorectal cancer by inhibiting sirtuin 1","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"37568","DOI":"10.18632\/oncotarget.17247","article-title":"Repositioning chlorpromazine for treating chemoresistant glioma through the inhibition of cytochrome c oxidase bearing the COX4-1 regulatory subunit","volume":"8","author":"Oliva","year":"2017","journal-title":"Oncotarget"},{"key":"ref_19","first-page":"107","article-title":"Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth","volume":"15","author":"Shtaif","year":"2006","journal-title":"Oncol. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00280-003-0738-1","article-title":"Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes: Phenothiazines and leukemia","volume":"53","author":"Zhelev","year":"2004","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e1111","DOI":"10.1038\/cddis.2014.56","article-title":"Harnessing the lysosome-dependent antitumor activity of phenothiazines in human small cell lung cancer","volume":"5","author":"Zong","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Jeong, J.Y., Park, H., Yoo, H., Kim, E.J., Jeon, B., Lee, J.D., Kang, D., Lee, C.J., Paek, S.H., and Roh, E.J. (2022). Trifluoperazine and Its Analog Suppressed the Tumorigenicity of Non-Small Cell Lung Cancer Cell; Applicability of Antipsychotic Drugs to Lung Cancer Treatment. Biomedicines, 10.","DOI":"10.3390\/biomedicines10051046"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"15756","DOI":"10.1002\/jcb.28845","article-title":"Trifluoperazine as an alternative strategy for the inhibition of tumor growth of colorectal cancer","volume":"120","author":"Qian","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"ref_24","first-page":"CD009396","article-title":"Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia","volume":"7","author":"Tardy","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.21873\/anticanres.11153","article-title":"The Anticancer Activity of the Old Neuroleptic Phenothiazine-type Drug Thioridazine","volume":"36","author":"Spengler","year":"2016","journal-title":"Anticancer Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.canlet.2018.01.058","article-title":"Repurposing psychiatric drugs as anti-cancer agents","volume":"419","author":"Huang","year":"2018","journal-title":"Cancer Lett."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.2146\/ajhp060505","article-title":"Evidence-based review of the black-box warning for droperidol","volume":"64","author":"Jackson","year":"2007","journal-title":"Am. J. Health Syst. Pharm."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jemermed.2014.12.024","article-title":"American Academy of Emergency Medicine Position Statement: Safety of Droperidol Use in the Emergency Department","volume":"49","author":"Perkins","year":"2015","journal-title":"J. Emerg. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/EJA.0b013e328352813f","article-title":"Low-dose droperidol (<\/=1 mg or <\/=15 mug kg-1) for the prevention of postoperative nausea and vomiting in adults: Quantitative systematic review of randomised controlled trials","volume":"29","author":"Schaub","year":"2012","journal-title":"Eur. J. Anaesthesiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1463-1326.2010.01304.x","article-title":"Bromocriptine: Old drug, new formulation and new indication","volume":"12","author":"Holt","year":"2010","journal-title":"Diabetes Obes. Metab."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/sarh.2001.25482","article-title":"Bromocriptine in rheumatic and autoimmune diseases","volume":"31","author":"McMurray","year":"2001","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/1440-1681.13049","article-title":"Inhibition of cancer stem cells promoted by Pimozide","volume":"46","author":"Goncalves","year":"2019","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.semcancer.2019.10.007","article-title":"Repurposing antipsychotics of the diphenylbutylpiperidine class for cancer therapy","volume":"68","author":"Shaw","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4081\/oncol.2019.411","article-title":"Prospects for repurposing CNS drugs for cancer treatment","volume":"13","author":"Abdelaleem","year":"2019","journal-title":"Oncol. Rev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1177\/2045125314553610","article-title":"Clozapine treatment of refractory schizophrenia during essential chemotherapy: A case study and mini review of a clinical dilemma","volume":"4","author":"Usta","year":"2014","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41398-021-01613-2","article-title":"Efficacy and safety of clozapine in psychotic disorders-a systematic quantitative meta-review","volume":"11","author":"Wagner","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Gammon, D., Cheng, C., Volkovinskaia, A., Baker, G.B., and Dursun, S.M. (2021). Clozapine: Why Is It So Uniquely Effective in the Treatment of a Range of Neuropsychiatric Disorders?. Biomolecules, 11.","DOI":"10.3390\/biom11071030"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.cell.2012.03.049","article-title":"Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells","volume":"149","author":"Sachlos","year":"2012","journal-title":"Cell"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/B978-0-12-397220-0.00008-8","article-title":"Risperidone","volume":"37","author":"Germann","year":"2012","journal-title":"Profiles Drug Subst. Excip. Relat. Methodol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1517\/14656566.6.5.803","article-title":"Risperidone: A review","volume":"6","year":"2005","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.schres.2016.10.035","article-title":"Risk of breast cancer in risperidone users: A nationwide cohort study","volume":"182","author":"Reutfors","year":"2017","journal-title":"Schizophr. Res."},{"key":"ref_42","first-page":"1151","article-title":"Association of risperidone with gastric cancer: Triangulation method from cell study, animal study, and cohort study","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pnpbp.2011.08.010","article-title":"Neurotoxic\/neuroprotective activity of haloperidol, risperidone and paliperidone in neuroblastoma cells","volume":"36","author":"Mas","year":"2012","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Chen, V.C.-H., Hsieh, Y.-H., Lin, T.-C., Lu, M.-L., Liao, Y.-T., Yang, Y.-H., Hsu, T.-C., Stewart, R., Weng, J.-C., and Lee, M.-J. (2020). New use for old drugs: The protective effect of risperidone on colorectal cancer. Cancers, 12.","DOI":"10.3390\/cancers12061560"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1517\/14656566.1.3.555","article-title":"Cabergoline","volume":"1","author":"Colao","year":"2000","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2165\/00003088-200342070-00003","article-title":"Clinical pharmacokinetics of cabergoline","volume":"42","author":"Bonuccelli","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/COC.0000000000000505","article-title":"Cabergoline in the Management of Residual Nonfunctioning Pituitary Adenoma: A Single-Center, Open-Label, 2-Year Randomized Clinical Trial","volume":"42","author":"Batista","year":"2019","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10549-017-4370-x","article-title":"A pilot study of cabergoline for the treatment of metastatic breast cancer","volume":"165","author":"Costa","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11864-020-00804-1","article-title":"The Benefits of Olanzapine in Palliating Symptoms","volume":"22","author":"Davis","year":"2020","journal-title":"Curr. Treat Options Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Saudemont, G., Prod\u2019Homme, C., Da Silva, A., Villet, S., Reich, M., Penel, N., and Gamblin, V. (2020). The use of olanzapine as an antiemetic in palliative medicine: A systematic review of the literature. BMC Palliat. Care, 19.","DOI":"10.1186\/s12904-020-00559-4"},{"key":"ref_51","first-page":"e1167","article-title":"Efficacy of olanzapine for quality of life improvement among patients with malignant tumor: A systematic review","volume":"2","author":"Ji","year":"2019","journal-title":"Cancer"},{"key":"ref_52","first-page":"6177","article-title":"Olanzapine, an Atypical Antipsychotic, Inhibits Surviving Expression and Sensitizes Cancer Cells to Chemotherapeutic Agents","volume":"37","author":"Sanomachi","year":"2017","journal-title":"Anticancer Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2174\/157488610791698334","article-title":"Domperidone and long QT syndrome","volume":"5","author":"Rossi","year":"2010","journal-title":"Curr. Drug Saf."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.cgh.2008.02.065","article-title":"A systematic review of the efficacy of domperidone for the treatment of diabetic gastroparesis","volume":"6","author":"Sugumar","year":"2008","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/FJC.0b013e31827afd0d","article-title":"Domperidone: Limited benefits with significant risk for sudden cardiac death","volume":"61","author":"Hondeghem","year":"2013","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1038\/onc.2015.484","article-title":"Moderate swimming suppressed the growth and metastasis of the transplanted liver cancer in mice model: With reference to nervous system","volume":"35","author":"Zhang","year":"2016","journal-title":"Oncogene"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"74380","DOI":"10.18632\/oncotarget.11814","article-title":"Discovery and clinical introduction of first-in-class imipridone ONC201","volume":"7","author":"Allen","year":"2016","journal-title":"Oncotarget"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.neo.2020.09.005","article-title":"ONC201 and imipridones: Anti-cancer compounds with clinical efficacy","volume":"22","author":"Prabhu","year":"2020","journal-title":"Neoplasia"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/11\/7\/1917\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:07:32Z","timestamp":1760126852000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/11\/7\/1917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,6]]},"references-count":58,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["biomedicines11071917"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines11071917","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,6]]}}}